Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Screening for prostate cancer: an updated Cochrane systematic review.

Ilic D, O'Connor D, Green S, Wilt TJ.

BJU Int. 2011 Mar;107(6):882-91. doi: 10.1111/j.1464-410X.2010.10032.x. Review.

PMID:
21392207
[PubMed - indexed for MEDLINE]
2.

Screening for prostate cancer: a Cochrane systematic review.

Ilic D, O'Connor D, Green S, Wilt T.

Cancer Causes Control. 2007 Apr;18(3):279-85. Epub 2007 Jan 6. Review.

PMID:
17206534
[PubMed - indexed for MEDLINE]
3.

Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.

Mian BM.

Urol Oncol. 2010 May-Jun;28(3):233-6. doi: 10.1016/j.urolonc.2009.11.011. Epub 2010 Jan 25. No abstract available.

PMID:
20097584
[PubMed - indexed for MEDLINE]
4.

Screening for prostate cancer.

Schröder FH.

Urol Clin North Am. 2003 May;30(2):239-51, viii. Review.

PMID:
12735501
[PubMed - indexed for MEDLINE]
5.

Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group.

Auvinen A, Rietbergen JB, Denis LJ, Schröder FH, Prorok PC.

J Med Screen. 1996;3(2):97-104.

PMID:
8849769
[PubMed - indexed for MEDLINE]
6.

Simulated screening for prostate cancer: the useful model.

Church TR.

J Natl Cancer Inst. 2003 Jun 18;95(12):838-9. No abstract available.

PMID:
12813160
[PubMed - indexed for MEDLINE]
Free Article
7.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
[PubMed - indexed for MEDLINE]
8.

Screening and early detection of prostate cancer.

Schröder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS.

Prostate. 2000 Aug 1;44(3):255-63. Review. No abstract available.

PMID:
10906743
[PubMed - indexed for MEDLINE]
9.

The Japanese guideline for prostate cancer screening.

Hamashima C, Nakayama T, Sagawa M, Saito H, Sobue T.

Jpn J Clin Oncol. 2009 Jun;39(6):339-51. doi: 10.1093/jjco/hyp025. Epub 2009 Apr 4.

PMID:
19346535
[PubMed - indexed for MEDLINE]
Free Article
10.

Rural residence and prostate cancer screening with prostate-specific antigen.

Stamatiou K, Skolarikos A.

Rural Remote Health. 2009 Apr-Jun;9(2):1227. Epub 2009 Jun 18.

PMID:
19594290
[PubMed - indexed for MEDLINE]
Free Article
11.

Two randomized screening trials with prostate cancer mortality, two interim results: a consideration of usual-care window in screening trials.

Song Y.

Contemp Clin Trials. 2010 Jul;31(4):378-80. doi: 10.1016/j.cct.2010.04.005. Epub 2010 May 9.

PMID:
20450987
[PubMed - indexed for MEDLINE]
12.

Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

Vutuc C, Schernhammer ES, Haidinger G, Waldhör T.

Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61.

PMID:
16091872
[PubMed - indexed for MEDLINE]
13.

[Screening for prostate cancer--what does the evidence show?].

Borre M, Iversen P.

Ugeskr Laeger. 2007 May 14;169(20):1887-8. Review. Danish.

PMID:
17553362
[PubMed - indexed for MEDLINE]
14.

Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.

Miller AB, Madalinska JB, Church T, Crawford D, Essink-Bot ML, Goel V, de Koning HJ, Määttänen L, Pentikäinen T.

Eur J Cancer. 2001 Nov;37(17):2154-60. Review.

PMID:
11677101
[PubMed - indexed for MEDLINE]
15.

Prostate cancer screening: what we know and what we need to know.

Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK.

Ann Intern Med. 1993 Nov 1;119(9):914-23.

PMID:
7692780
[PubMed - indexed for MEDLINE]
16.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
[PubMed - indexed for MEDLINE]
17.

Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction.

Boer R, Schröder FH.

Prostate. 1999 Jul 1;40(2):130-4. No abstract available.

PMID:
10386474
[PubMed - indexed for MEDLINE]
18.

Prostate cancer screening: what we have learned from the PLCO and ERSPC trials.

La Rochelle J, Amling CL.

Curr Urol Rep. 2010 May;11(3):198-201. doi: 10.1007/s11934-010-0109-5. Review.

PMID:
20425627
[PubMed - indexed for MEDLINE]
19.

The Finnish trial of prostate cancer screening: where are we now?

Finne P, Stenman UH, Määttänen L, Mäkinen T, Tammela TL, Martikainen P, Ruutu M, Ala-Opas M, Aro J, Karhunen PJ, Lahtela J, Rissanen P, Juusela H, Hakama M, Auvinen A.

BJU Int. 2003 Dec;92 Suppl 2:22-6. No abstract available.

PMID:
14983949
[PubMed - indexed for MEDLINE]
20.

Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group.

[No authors listed]

Eur J Cancer. 1999 Feb;35(2):262-71. Review.

PMID:
10448269
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk